Collectively, these data suggest that delayed neutrophil apoptosis induced by tumor‐derived G‐CSF/GM‐CSF is associated with an increased percentage of viable CXCR4+ neutrophils in vitro. The gene discussed is CSF2; the disease is neoplasm.